Ethics of placebo controlled studies of inhaled steroids for COPD [3] (multiple letters)

Thorax

Volumn 59, Issue 6, 2004, Pages 539-540

  Hahn, D L ^a   Burge, P S ^b   Lewis, S A ^c  

^a DEAN MEDICAL CENTER   (United States)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

AIRWAY OBSTRUCTION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; CORTICOSTEROID THERAPY; DRUG EFFECT; EVALUATION; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; MEDICAL ETHICS; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ETHICS; INHALATIONAL DRUG ADMINISTRATION; NOTE; RANDOMIZED CONTROLLED TRIAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; FORCED EXPIRATORY VOLUME; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS;

EID: 2942670613     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)